If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
360.00    10.00 (2.86%)
Bid:
350.00
Ask:
370.00
Spread: 20.00 (5.714%)
Market Cap: £62.78m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

29 Jul 2024 14:00

RNS Number : 2214Y
Triad Group Plc
29 July 2024
 

Triad Group Plc

("Triad" or "the Company")

Director Dealings

The Company announces that it has been informed that, on 25 July 2024, Tim Eckes (Client Services Director) has in order to effect a "Bed and ISA" transaction, sold 6,678 ordinary shares of £0.01 each ("Ordinary Shares") at a price of 284.00 pence per Ordinary Share and then repurchased into his Individual Savings Account (ISA), the same number of 6,678 Ordinary Shares at an average price of 284.60 pence per Ordinary Share.

Following the completion of these transactions his ultimate beneficial ownership is unchanged and remains at 120,374 Ordinary Shares in total, representing approximately 0.72% of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transactions.

1.

Details of PDMR / person closely associated with them

a)

Name

Tim Eckes

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Triad Group Plc

b)

LEI

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary shares of £0.01 each

 

 

ISIN: GB0009035741

b)

Nature of the transaction

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.8400 (sale)

£2.8450 (purchase)

£2.9840 (purchase)

6,678

6,632

46

d)

Aggregated information

-Aggregated sale

-Aggregated purchase

 

6,678 - average price of £2.8400

6,678 - average price of £2.8460

e)

Date of the transaction

25 July 2024

f)

Place of the transaction

LONDON STOCK EXCHANGE XLON

 

For further information, please contact:

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Zeus Capital Limited

Alexandra Campbell-Harris

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKORRSNUBUAR
Date   Source Headline
12th Apr 20224:30 pmRNSHolding(s) in Company
31st Mar 20224:30 pmRNSGrant of Restrictive Share Units
25th Mar 20224:45 pmRNSResult of Meeting
14th Mar 20224:00 pmRNSBlock listing six monthly return
10th Mar 20224:30 pmRNSNotice of GM
21st Feb 20224:30 pmRNSDirector/PDMR Shareholding
14th Feb 20224:00 pmRNSDirector/PDMR Shareholding
21st Jan 202210:00 amRNSDirector/PDMR Shareholding
20th Jan 20225:45 pmRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSTotal Voting Rights
25th Nov 202112:00 pmRNSDirector/PDMR Shareholding
22nd Nov 202112:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20217:00 amRNSHalf-year Report
25th Oct 20219:05 amRNSSecond Price Monitoring Extn
25th Oct 20219:00 amRNSPrice Monitoring Extension
14th Sep 20214:00 pmRNSBlock listing
31st Aug 20214:00 pmRNSTotal Voting Rights
30th Jul 20214:00 pmRNSTotal Voting Rights
28th Jul 20215:00 pmRNSResult of AGM
5th Jul 20214:00 pmRNSNotice of AGM
5th Jul 20214:00 pmRNSDividend Declaration
30th Jun 20215:00 pmRNSTotal Voting Rights
15th Jun 20214:41 pmRNSSecond Price Monitoring Extn
15th Jun 20214:36 pmRNSPrice Monitoring Extension
15th Jun 20212:05 pmRNSSecond Price Monitoring Extn
15th Jun 20212:00 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSFinal Results
7th May 20214:00 pmRNSTotal Voting Rights
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20213:00 pmRNSDirector/PCA Dealings
15th Mar 20213:00 pmRNSBlock listing six monthly return
8th Mar 20214:41 pmRNSSecond Price Monitoring Extn
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20212:06 pmRNSSecond Price Monitoring Extn
8th Mar 20212:00 pmRNSPrice Monitoring Extension
5th Mar 20214:00 pmRNSDirector/PCA Dealings
23rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20212:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:00 pmRNSPrice Monitoring Extension
23rd Feb 202111:05 amRNSSecond Price Monitoring Extn
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 202112:00 pmRNSHolding(s) in Company
18th Feb 20212:06 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 202111:05 amRNSSecond Price Monitoring Extn
18th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20219:05 amRNSSecond Price Monitoring Extn
18th Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.